Samuel O'Brient

Samuel O'Brient

Expertise: Global Financial Markets, Macroeconomics and Geopolitics

Education: BA, Economics & Political Science, Sarah Lawrence College; MSc, International Politics, Trinity College Dublin

Awards & Accomplishments: Published in Curlew Quarterly. Quoted in Forbes. Interviewed by Foreign Policy.

About Samuel
Samuel O’Brient is a Reporter for InvestorPlace, where his work focuses primarily on financial markets, global economic trends, and public policy. O’Brient writes a weekly column on recent political news that investors should be following.

From his early days at InvestorPlace, O’Brient found himself drawn to the booming world of electric vehicles and green energy. His coverage of mining and other battery components has made him an expert source for industry publications. During his early years as an Economic Policy Analyst at U.S. Resist News, he gained expertise in international trade as the U.S.-China trade war dominated headlines. This in-depth research and analysis experience helped strengthen his prowess in all things political economy. O’Brient brings this expertise to work with him every day, thoughtfully analyzing how the daily happenings on the Capitol trickle down to Wall Street… and how retail investors can take action to profit.

An experienced journalist, editor, and economic policy analyst, O’Brient has spent his career guided by a deep passion for economic theory and policy. As a financial blogger on TipRanks, he has received 4.6 stars and is ranked in the top 10% of stock pickers.

O’Brient’s work on economic and tech policy has been curated by popular outlets Marker, OneZero and Gen.

He can be reached on LinkedIn and Muck Rack.

Recent Articles

Coinbase Price Predictions: Why One Analyst Thinks COIN Stock Can Hit $300

It's been a tough week for crypto and for Coinbase, but one analyst thinks that better days are ahead for COIN stock.

WRBY Stock IPO: 10 Things to Know Before Warby Parker Starts Trading Tomorrow

Tomorrow marks Warby Parker's public debut and investors should keep their eyes on WRBY stock as it begins to trade.

ALT Stock: One Analyst Still Thinks Altimmune Prices Could Hit $34

Some clinical trial results released by Altimmune have shareholders rushing to sell. But, one analyst sees plenty of upside for ALT stock.

LCID Stock Dips Tuesday Despite ‘Electric’ Lucid Event Update

Lucid Motors' Production Week is here and despite some declines today, LCID stock is about to take off as the factory doors open up.

Aurora Cannabis Price Predictions: Where Is ACB Stock Going After Earnings?

Aurora Cannabis predicts a green year ahead, but analysts are still bearish on ACB stock. See what they are saying about this company.